2026-01-02 - Analysis Report
Okay, here's a breakdown and analysis of Tempus AI (TEM) based on the provided data.

**1. Return Rate vs. S&P 500 (VOO)**

*   **TEM Overview:** Tempus AI Inc. is a technology company focused on precision medicine through data and artificial intelligence.
*   **TEM Cumulative Return:** 5.46%
*   **VOO Cumulative Return:** 28.60%
*   **Divergence:** -25.1 (Relative Divergence: 13.5)

    *   **Analysis:** TEM has significantly underperformed the S&P 500 (VOO). The divergence of -25.1% indicates a considerable gap in cumulative returns. The relative divergence of 13.5 suggests that this underperformance is currently near the lower end of its historical range compared to the S&P 500.

**Alpha, Beta Analysis**

|            | CAGR   | MDD    | Alpha   | Beta | Cap(B) |
|------------|--------|--------|---------|------|--------|
| 2023-2025  | -31.0% | 99.9%  | -59.0%  | 2.8  | 10.5   |

*   **CAGR (Compound Annual Growth Rate):** -31.0%.  Significant negative growth over the analyzed period.
*   **MDD (Maximum Drawdown):** 99.9%. Extremely high, indicating massive potential loss from peak to trough.
*   **Alpha:** -59.0%.  Indicates TEM has significantly underperformed its benchmark on a risk-adjusted basis.
*   **Beta:** 2.8. TEM is much more volatile than the market. A beta of 2.8 suggests that for every 1% move in the market, TEM tends to move 2.8% in the same direction.
*   **Cap(B):** 10.5 Billion (USD).

**2. Recent Stock Price Fluctuations**

*   **Current Close:** $59.05
*   **Previous Close:** $60.39
*   **Change:** -$1.34 (-2.22%)
*   **5-day SMA:** $61.57
*   **20-day SMA:** $68.35
*   **60-day SMA:** $77.41

    *   **Analysis:** TEM's price is below all three Simple Moving Averages (SMAs), indicating a downtrend in the short, medium, and long term. The recent drop below the 5-day SMA is also negative. The recent change of -2.22% shows an issue with fluctuations.

**3. RSI, PPO, and Market Risk Indicators**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 15.83 (Oversold)
*   **PPO:** -1.09 (Bearish Momentum)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (14 shares - Very Safe - MRI:0.90) Monthly invest 5.0% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** -7.3 (Negative - Short-term decline)
*   **Expected Return (%):** 0.0%

    *   **Analysis:**  The RSI is deeply in oversold territory (below 30), suggesting a potential for a rebound. The PPO is negative, indicating bearish momentum. The MRI is quite contradictory and should be reviewed given the other indicators. The Hybrid Signal and Expected Return are not a great signal for return. The negative change in relative divergence over the past 20 days confirms recent underperformance.

**4. Recent News & Significant Events (Yahoo Finance)**

*   The news headlines present a mixed picture:
    *   **Positive:** "3 MedTech Stocks Poised to Gain in 2026 From the AI Boom," "Tempus AI: A Healthcare Hyper-Growth Opportunity For The Risk Tolerant"
    *   **Neutral/Questioning:** "Is TEM Stock a Buy, Hold, or Sell During Its Pivotal Transition?" (Appears in multiple sources)
    *   **Negative:** "JPMorgan Chase & Co. Has Lowered Expectations for Tempus AI (NASDAQ:TEM) Stock Price," "Tempus AI, Inc. Stock (TEM) Opinions on FDA Clearance and Price Drop"

**4-2) Analyst Opinions**

*   **Consensus:** Buy (~2.14) based on 12 opinions
*   **Target Price:** Average $88.92 (High $105, Low $80)
*   **Recent Rating Changes:**  No recent rating changes are available based on your input.

    *   **Analysis:** Analysts, on average, have a "Buy" rating with a significant price target upside. However, the recent news suggests that expectations might be getting tempered.

**5. Comprehensive Analysis**

Based on the provided information, here's a summary:

*   **Performance:** TEM has significantly underperformed the S&P 500, demonstrating a clear downtrend.
*   **Volatility:**  TEM is much more volatile than the market.
*   **Technical Indicators:** The stock is currently oversold, but recent momentum is bearish.
*   **News Sentiment:** Mixed, with some positive outlooks but also concerns about lowered expectations and transitions.
*   **Analyst Sentiment:** Generally positive, with a "Buy" consensus and high price targets.

**Overall Conclusion:**

Investing in Tempus AI right now would be a high-risk, high-reward proposition.

*   **Risks:** The negative CAGR, extremely high MDD, significant underperformance relative to the market, and negative momentum indicators are major concerns. Recent news also points to some headwinds.
*   **Potential Rewards:** The oversold conditions, positive analyst ratings, and the potential for future growth in the AI-driven medtech space could lead to significant gains.  The "Hyper-Growth Opportunity" article suggests a long-term, high-risk, high-reward scenario.

**Recommendation:**

A cautious approach is advised. A potential investor should conduct thorough due diligence, carefully weigh the risks and rewards, and potentially wait for more positive signals before investing. The conflicting signals from MRI and other indicators warrant further investigation. Considering the mixed news, paying close attention to the company's progress on FDA clearances and its strategic "pivotal transition" is crucial.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.